Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.

[1]  Zijian Guo,et al.  Targeting and delivery of platinum-based anticancer drugs. , 2013, Chemical Society reviews.

[2]  H. Maeda.  Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[3]  X. Jing,et al.  Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[4]  X. Jing,et al.  A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance. , 2012, Biomaterials.

[5]  A. Pandey,et al.  Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity , 2012, Proceedings of the National Academy of Sciences.

[6]  X. Jing,et al.  Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[7]  M. Suckow,et al.  Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo , 2012, Blood cancer journal.

[8]  Daan Frenkel,et al.  Receptor-mediated endocytosis of nanoparticles of various shapes. , 2011, Nano letters.

[9]  A. Quiroga.  Non-classical structures among current platinum complexes with potential as antitumor drugs. , 2011 .

[10]  X. Jing,et al.  Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II). , 2011, Biomaterials.

[11]  Kirsten Sandvig,et al.  Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .

[12]  Shonagh Walker,et al.  The status of platinum anticancer drugs in the clinic and in clinical trials. , 2010, Dalton transactions.

[13]  Gianfranco Pasut,et al.  PEG conjugates in clinical development or use as anticancer agents: an overview. , 2009, Advanced drug delivery reviews.

[14]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[15]  P. Sadler,et al.  A potent cytotoxic photoactivated platinum complex , 2007, Proceedings of the National Academy of Sciences.

[16]  Celia Quevedo,et al.  Biochemical mechanisms of cisplatin cytotoxicity. , 2007, Anti-cancer agents in medicinal chemistry.

[17]  P. Sadler,et al.  Photoactivatable platinum complexes. , 2007, Anti-cancer agents in medicinal chemistry.

[18]  Mika Kettunen,et al.  Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. , 2006, Current medicinal chemistry.

[19]  M. Hall,et al.  The Discovery and Development of Cisplatin , 2006 .

[20]  M. Jakupec,et al.  Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches. , 2005, Current medicinal chemistry.

[21]  M. Hall,et al.  The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. , 2004, Journal of inorganic biochemistry.

[22]  T. Boulikas,et al.  Cisplatin and platinum drugs at the molecular level. (Review). , 2003, Oncology reports.

[23]  J. Collins,et al.  Multi-nuclear platinum complexes as anti-cancer drugs , 2003 .

[24]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[25]  J. Perez,et al.  Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. , 2003, Current medicinal chemistry.

[26]  M. Hall,et al.  Platinum(IV) antitumour compounds: their bioinorganic chemistry , 2002 .

[27]  José Perez,et al.  Is cisplatin-induced cell death always produced by apoptosis? , 2001, Molecular pharmacology.

[28]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[29]  N. Nissen,et al.  Membrane transport of anthracyclines. , 1982, Pharmacology & therapeutics.